Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorecivivint Phase 2 in Knee Osteoarthritis
NCT02536833Phase 2Completed
- Sponsor
- Biosplice Therapeutics
- Start
- Sep 2015
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lorecivivint in osteoarthritis (OA), sponsored by Biosplice Therapeutics. Started Sep 2015; status: completed.
02
Drugs
lorecivivint
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02536833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02536833.